| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-10 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |